Liver Diseases  >>  arsenic trioxide  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
arsenic trioxide / Generic mfg.
NCT00024258: Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

Completed
2
22
US
arsenic trioxide
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Kidney Cancer, Liver Cancer, Neuroblastoma, Ovarian Cancer, Retinoblastoma, Sarcoma
05/09
05/09
NCT00582400: A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver

Terminated
2
9
US
arsenic trioxide, Trisenox
The University of Texas Medical Branch, Galveston
Carcinoma, Hepatocellular
04/10
04/10

Download Options